Vitamin B1 (Thiamine) for Fatigue

Verdict: Weak, conflicting evidence; works only for deficiency

Vitamin B1 (thiamine) reliably relieves fatigue only when that fatigue stems from a genuine thiamine deficiency. For everyday tiredness in well-nourished people, the human evidence is weak and contradictory, and no major regulator or clinic endorses it for this use.

C 🟠 C Weak Evidence Published

🔬Why this grade7-layer evidence engine

This claim earns a Weak (Tier C) grade because the only direct human trials are small and pull in opposite directions. A double-blind RCT in quiescent inflammatory bowel disease (PMID 33210299, n=40) found high-dose oral thiamine meaningfully cut chronic fatigue, but a similarly designed double-blind crossover trial in primary biliary cholangitis (PMID 38551983, n=34) found no benefit over placebo (p=0.55). The remaining support is an uncontrolled three-patient case report in Hashimoto's thyroiditis (PMID 24351023), which is too weak to establish efficacy.

Regulators and major clinics back thiamine only within a deficiency framework, not as a general anti-fatigue supplement. EFSA recognizes thiamine's role in normal energy-yielding metabolism, but this is a biochemical-function statement, not a treatment claim, and EFSA notably never authorized a 'reduction of tiredness and fatigue' claim for B1 (unlike several other B vitamins). The NIH Office of Dietary Supplements and Cleveland Clinic note that fatigue is an early sign of B1 deficiency, while Mayo Clinic, Harvard, and the UK NHS do not endorse routine supplementation for healthy adults.

Taken together, thiamine clearly helps when fatigue is driven by a true deficiency, but for non-deficient people the contradictory trial results and absence of any large RCT or guideline support justify only a weak, inconclusive verdict. Anyone with persistent fatigue is better served by addressing sleep, diet, and underlying medical causes than by assuming a B1 shortfall.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.44
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published
Confidence
88%
Highly consistent evidence
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L2 PubMedPrimary literature
0.40
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L5 Clinical bodiesAuthoritative stance
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.44
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease
PMID: 33210299 2021 RCT (double-blind) n = 40
Finding: Crossover analysis: mean fatigue reduction 4.5 points (95% CI 2.6-6.2) on thiamine vs +0.75 on placebo, p=0.0003.
Effect size: [object Object]
View on PubMed
High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial
PMID: 38551983 2024 RCT (double-blind) n = 34
Finding: Crossover analysis: fatigue +0.3 points on thiamine vs -1.4 on placebo, p=0.55; thiamine not superior to placebo.
Government Effect size: [object Object]
View on PubMed
Thiamine and Hashimoto's thyroiditis: a report of three cases
PMID: 24351023 2014 個案報告 n = 3
Finding: Partial-to-complete regression of fatigue within hours-to-days in 3 euthyroid Hashimoto patients (no control, no p-value).
🟠 Limited quality
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established between the dietary intake of thiamine and (a) contribution to normal energy-yielding metabolism, (b) contribution to normal neurological function, and (c) contribution to normal function of the heart. source↗
L4c UK NHS
Cautious
Thiamin (vitamin B1) helps: the body break down and release energy from food; keep the nervous system healthy. Adults aged 19 to 64 need about: 1mg a day of thiamin for men; 0.8mg a day of thiamin for women. You should be able to get all the thiamin you need from your daily diet. Thiamin cannot be stored in the body, so you need it in your diet every day. source↗
L4d TW TFDA / 衛福部
Supportive
維生素B1有助於維持能量正常代謝;維生素B1有助於維持皮膚、心臟及神經系統的正常功能;維生素B1有助於維持正常生長 source↗
L4e WHO
Supportive
Thiamine hydrochloride. Injection: 100 mg/mL in 1‑mL ampoule. Tablet: 50 mg (hydrochloride). — listed under 'Vitamins and minerals', WHO Model List of Essential Medicines. source↗
L5a NIH Office of Dietary Supplements
Supportive
Because of the lack of reports of adverse effects from high thiamin intakes (50 mg/day or more) from food or supplements, the FNB did not establish ULs for thiamin. Thiamin deficiency can cause loss of weight and appetite, confusion, memory loss, muscle weakness, and heart problems. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-fatigue-INT-vitamin-b1-001 繁體中文版 →